Key for crossing the BBB with nanoparticles: the rational design

• Sonia M. Lombardo,
• Marc Schneider,
• Akif E. Türeli and
• Nazende Günday Türeli

Beilstein J. Nanotechnol. 2020, 11, 866–883, doi:10.3762/bjnano.11.72

• targeting liposomal drug delivery system was then developed by conjugating peptide-22 and c(RGDfK), a ligand of integrin αvβ3 that showed ability to target glioma cells, to liposomes loaded with doxorubicin. This formulation was tested in vivo on an intracranial glioma-bearing mouse model. The nanocarrier

• the survival time of mice when loaded with paclitaxel. Thus, this formulation could be a promising drug delivery system for antitumor therapy. Solid lipid nanoparticles: Solid lipid nanoparticles (SLNs) are particles with a solid lipid core at room and body temperature [27]. SLNs can be prepared with

Multilayer capsules made of weak polyelectrolytes: a review on the preparation, functionalization and applications in drug delivery

• Varsha Sharma and
• Anandhakumar Sundaramurthy

Beilstein J. Nanotechnol. 2020, 11, 508–532, doi:10.3762/bjnano.11.41

• , theranostics and gene therapy. The most essential attributes of a drug delivery system are considered to be multi-functionality and stimuli responsiveness against a range of external and internal stimuli. Apart from the highly explored strong polyelectrolytes, weak polyelectrolytes offer great versatility with

Understanding nanoparticle flow with a new in vitro experimental and computational approach using hydrogel channels

• Armel Boutchuen,
• Dell Zimmerman,
• Abdollah Arabshahi,
• John Melnyczuk and
• Soubantika Palchoudhury

Beilstein J. Nanotechnol. 2020, 11, 296–309, doi:10.3762/bjnano.11.22

• transvascular transport through vascular networks of varying dimensions within the body, before reaching the action site [7][8][9]. It is increasingly complex to predict the flow properties of NP-based drug delivery system such as the local velocity and adhesion of the NPs in vivo. If we can predict the flow

Phase inversion-based nanoemulsions of medium chain triglyceride as potential drug delivery system for parenteral applications

• Eike Folker Busmann,
• Dailén García Martínez,
• Henrike Lucas and
• Karsten Mäder

Beilstein J. Nanotechnol. 2020, 11, 213–224, doi:10.3762/bjnano.11.16

Internalization mechanisms of cell-penetrating peptides

• Ivana Ruseska and
• Andreas Zimmer

Beilstein J. Nanotechnol. 2020, 11, 101–123, doi:10.3762/bjnano.11.10

Frontiers in pharmaceutical nanotechnology

• Matthias G. Wacker

Beilstein J. Nanotechnol. 2019, 10, 2538–2540, doi:10.3762/bjnano.10.244

• active transport of nanoparticles into the central nervous system using the low-density lipoprotein receptor family [3][4][5][6], provided an entry route for the cytostatic drug doxorubicin into the brain. The drug delivery system has been tested in a phase II clinical trial and hopefully will make its

Design of a nanostructured mucoadhesive system containing curcumin for buccal application: from physicochemical to biological aspects

• Sabrina Barbosa de Souza Ferreira,
• Gustavo Braga,
• Évelin Lemos Oliveira,
• Jéssica Bassi da Silva,
• Hélen Cássia Rosseto,
• Lidiane Vizioli de Castro Hoshino,
• Mauro Luciano Baesso,
• Wilker Caetano,
• Craig Murdoch,
• Helen Elizabeth Colley and
• Marcos Luciano Bruschi

Beilstein J. Nanotechnol. 2019, 10, 2304–2328, doi:10.3762/bjnano.10.222

• released from the drug delivery system and how the applied technology influences the availability of the drug. Another aspect to be considered for the in vitro drug release analysis is the choice of release medium. For hydrophobic drugs, sometimes it is necessary to add surfactants that can provide the

Microfluidics as tool to prepare size-tunable PLGA nanoparticles with high curcumin encapsulation for efficient mucus penetration

• Nashrawan Lababidi,
• Valentin Sigal,
• Aljoscha Koenneke,
• Konrad Schwarzkopf,
• Andreas Manz and
• Marc Schneider

Beilstein J. Nanotechnol. 2019, 10, 2280–2293, doi:10.3762/bjnano.10.220

• microfluidics in combination with a specific muco-inert surface chemistry led to a promising drug delivery system with enhanced mucus penetration. Moreover, a high absolute curcumin encapsulation efficiency of ≈67.15% was obtained using microfluidics. Furthermore, the encapsulation was clearly improved in

Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe₂O₄/silica/cisplatin nanocomposite formulation

• B. Rabindran Jermy,
• Vijaya Ravinayagam,
• Widyan A. Alamoudi,
• Dana Almohazey,
• Hatim Dafalla,
• Lina Hussain Allehaibi,
• Abdulhadi Baykal,
• Muhammet S. Toprak and
• Thirunavukkarasu Somanathan

Beilstein J. Nanotechnol. 2019, 10, 2217–2228, doi:10.3762/bjnano.10.214

• tumor imaging guide and drug delivery system. Keywords: anticancer; cisplatin; copper ferrite; drug delivery; multifunctional; nanomedicine; nanotherapeutics; spherical silica; tumour therapy; Introduction Due to the continuous advancements in the field of nanotechnology, the therapeutic prospects

• expected health crisis [1]. However, the single modal drug delivery system is hampered by low bioavailability (about 5–10%), burst release, and lower target efficiency. Multifunctional theranostic nanoparticles that can respond to an external magnetic field for drug release and assist in bioimaging

Synthesis and potent cytotoxic activity of a novel diosgenin derivative and its phytosomes against lung cancer cells

• Liang Xu,
• Dekang Xu,
• Ziying Li,
• Yu Gao and
• Haijun Chen

Beilstein J. Nanotechnol. 2019, 10, 1933–1942, doi:10.3762/bjnano.10.189

• targeted drug delivery to tumors. These nanoparticles can passively accumulate in tumors via enhanced permeability and retention (EPR) effect, thus decreasing the toxicity of nonselective bio-distribution [27]. Considering the advantages of liposomes as a drug delivery system for chemotherapeutic drugs and

• between cells treated with free drugs and their corresponding phytosomes. The results indicated that phytosomes could be an ideal drug delivery system for Di and its derivatives to obtain sustained release without affecting drug activity. In vitro anticancer mechanisms of P2P Cell cycle and cell apoptosis

Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting

• Xianping Liu,
• Chengjuan Du,
• Haichun Li,
• Ting Jiang,
• Zimiao Luo,
• Zhiqing Pang,
• Daoying Geng and
• Jun Zhang

Beilstein J. Nanotechnol. 2019, 10, 1860–1872, doi:10.3762/bjnano.10.181

• radical surgery [36]. In addition, Mao and co-workers have reported the multitargeted drug delivery system by a d-peptide ligand (d-AE) based EGFRvIII targeting strategy, which provides a promising path for glioma therapy [37]. Through the conjugation of Cy7.5 to PEPHC1-modified PEGylated SPIONs, a

• -coated iron oxide nanoparticles to target tumor-associated macrophages [36] and D-AE-peptide-modified micelles as a multitarget drug delivery system [37], the benefits of the nanoprobe in this study are described as follows. First, the nanoprobe has a diameter of around 100 nm and can directly pass

Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release

• Mohammad A. Obeid,
• Ibrahim Khadra,
• Abdullah Albaloushi,
• Margaret Mullin,
• Hanin Alyamani and
• Valerie A. Ferro

Beilstein J. Nanotechnol. 2019, 10, 1826–1832, doi:10.3762/bjnano.10.177

• nanoparticles components to be used as a drug delivery system for curcumin and for other therapeutic agents. TEM images of (A) SP80 niosomes prepared at 1:1 FRR, (B) SP80 niosomes prepared at 3:1 FRR, (C) T85 niosomes prepared at 1:1 FRR, (D) T85 niosomes prepared at 3:1 FRR. Curcumin standard curve measured by

Cytotoxicity of doxorubicin-conjugated poly[N-(2-hydroxypropyl)methacrylamide]-modified γ-Fe₂O₃ nanoparticles towards human tumor cells

• Zdeněk Plichta,
• Yulia Kozak,
• Rostyslav Panchuk,
• Viktoria Sokolova,
• Matthias Epple,
• Lesya Kobylinska,
• Pavla Jendelová and
• Daniel Horák

Beilstein J. Nanotechnol. 2018, 9, 2533–2545, doi:10.3762/bjnano.9.236

• the novel drug-delivery system, cytomorphological study of chromatin hypercondensation in DAPI-stained murine B16 melanoma cells was performed. Cells were incubated with γ-Fe2O3@PHPMA (Figure 10b,c), free Dox (Figure 10d,e), and γ-Fe2O3@P(HPMA-MMAA)-Dox nanoparticles (Figure 10f,g). Both free Dox and

Enhanced antineoplastic/therapeutic efficacy using 5-fluorouracil-loaded calcium phosphate nanoparticles

• Shanid Mohiyuddin,
• Saba Naqvi and
• Gopinath Packirisamy

Beilstein J. Nanotechnol. 2018, 9, 2499–2515, doi:10.3762/bjnano.9.233

• immediately on improving the efficacy. This need could possibly be met by a nanoscale-carrier-facilitated drug delivery system. This rapidly growing field of research has gained interest all over the world with its effective and targeted drug delivery application [3]. Polymer-based nanoformulations have

• insignificant drug release. On the other hand, with increased acidic conditions, there is an augmented probability of more H+ ions available to counteract the nanoparticle–drug formulation, thereby reducing the interactions [28]. This property of the proposed nanoparticle drug delivery system significantly

Nanoconjugates of a calixresorcinarene derivative with methoxy poly(ethylene glycol) fragments for drug encapsulation

• Alina M. Ermakova,
• Julia E. Morozova,
• Yana V. Shalaeva,
• Victor V. Syakaev,
• Aidar T. Gubaidullin,
• Alexandra D. Voloshina,
• Vladimir V. Zobov,
• Irek R. Nizameev,
• Olga B. Bazanova,
• Igor S. Antipin and
• Alexander I. Konovalov

Beilstein J. Nanotechnol. 2018, 9, 2057–2070, doi:10.3762/bjnano.9.195

• use as a supramolecular drug-delivery system. Keywords: calixresorcinarene; drug encapsulation; hemotoxicity; methoxy poly(ethylene glycol); temperature-controlled release; Introduction One of the acute problems of modern medicinal therapy is the development of novel drug-delivery systems with low

Biomimetic and biodegradable cellulose acetate scaffolds loaded with dexamethasone for bone implants

• Aikaterini-Rafailia Tsiapla,
• Varvara Karagkiozaki,
• Veroniki Bakola,
• Foteini Pappa,
• Panagiota Gkertsiou,
• Eleni Pavlidou and
• Stergios Logothetidis

Beilstein J. Nanotechnol. 2018, 9, 1986–1994, doi:10.3762/bjnano.9.189

• completed after 181 days. The burst release of the drug delivery system was very low (11.6%) and, consequently, this nanoplatform will not release the necessary amount of the drug to merge the immunosuppressive effect over a time scale of 181 days. In the same context, the choice of the CA scaffold, the

A visible-light-controlled platform for prolonged drug release based on Ag-doped TiO₂ nanotubes with a hydrophobic layer

• Caihong Liang,
• Jiang Wen and
• Xiaoming Liao

Beilstein J. Nanotechnol. 2018, 9, 1793–1801, doi:10.3762/bjnano.9.170

• anodizing voltage and time, some distinctive nanotube structures have been obtained, including multilayer [10], bamboo-type [11], branched tubes [12], and double-walled tubes [13]. Multilayered TNTs are known as the most controllable and useful drug delivery system [14]. In a previous work, Shi et al. [15

• . Thus, Zn exhibits significant, promising application in the biomedical field. Hence, Zn was selected as a model drug to be loaded into the TiO2 nanotubes for the drug delivery system in this work. In present work, we provide an approach for a visible-light-controlled drug release platform based on the

Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules

• María Francisca Matus,
• Martín Ludueña,
• Cristian Vilos,
• Iván Palomo and
• Marcelo M. Mariscal

Beilstein J. Nanotechnol. 2018, 9, 1328–1338, doi:10.3762/bjnano.9.126

• determine the spatial distribution of cilostazol in polymeric NPs and to explore its potential use in this kind of drug delivery system. Experimental Characterization of copolymer structures by all-atom molecular dynamics simulations The poly(lactic acid) core PLA polymer chains were built in three

Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery

• Gamze Varan,
• Juan M. Benito,
• Carmen Ortiz Mellet and
• Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1457–1468, doi:10.3762/bjnano.8.145

• used as a drug delivery system. This was a study regarding the non-polar anxiolytic drug diapezam realized by Mendez-Ardoy et al. [22]. Our goal is to evaluate the potential of the polycationic CD nanoparticles as an anticancer drug delivery system. In fact, these polycationic CDs were evaluated for

• their intrinsic apoptotic effect in our first paper [26] in unloaded blank nanoparticle form. This study focuses on the nanocarrier properties and drug delivery system potential of the polycationic CD nanoparticles for PCX, which is an anticancer drug with several serious bioavaibility and toxicity

• with zeta potential greater than +30 mV and less than −30 mV are considered as strongly charged [47]. According to this classification, two net positive nanoparticle formulations and a net negative nanoparticle formulation were used as a nanometer-sized drug delivery system for PCX in this study. These

Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment

• Cem Varan and
• Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1446–1456, doi:10.3762/bjnano.8.144

• than 100 nm and a net positive surface charge to facilitate cellular internalization of drug-loaded nanoparticles. Hydroxypropyl cellulose films were prepared to incorporate these nanoparticle dispersions to complete the implantable drug delivery system. Results: The diameter of core–shell

• nanoparticles and their zeta potential can be varied with chitosan coating. When further loaded into films, these nanoparticles seem to be a potential drug delivery system for docetaxel for glioma treatment and a good candidate for further evaluation in animal studies. This film formulation can be implanted

Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone

• Huijuan Zhang,
• Fuqiang Wu,
• Yazhen Li,
• Xiping Yang,
• Jiamei Huang,
• Tingting Lv,
• Yingying Zhang,
• Jianzhong Chen,
• Haijun Chen,
• Yu Gao,
• Guannan Liu and
• Lee Jia

Beilstein J. Nanotechnol. 2016, 7, 1861–1870, doi:10.3762/bjnano.7.178

• mechanism of action. However, application of MIF is limited by its poor water solubility and low oral bioavailability. In this work, we developed a drug delivery system based on chitosan nanoparticles (CNs) to improve its bioavailability and anticancer activity. The MIF-loaded chitosan nanoparticles (MCNs

• increased its efficacy by sustained release to reduce drug crystallization [33]. These results suggested that MCNs might be a good drug delivery system for delivery of MIF for cancer therapy. Pharmacokinetic study In our previous study, we found MIF showed distinct pharmacokinetic differences between

• MIF to increase its relative bioavailability. Conclusion In conclusion, CNs were employed as a drug delivery system for MIF delivery to improve the bioavailability of MIF, and consequently, to enhance the antitumor effect of MIF by the auxiliary anticancer functionality of Cs. MCNs prepared by an

Comparison of the interactions of daunorubicin in a free form and attached to single-walled carbon nanotubes with model lipid membranes

• Dorota Matyszewska

Beilstein J. Nanotechnol. 2016, 7, 524–532, doi:10.3762/bjnano.7.46

• includes liposomes, which are commercially available daunorubicin formulation (Daunoxome®) used in the treatment of Kaposi’s sarcoma [6]. Despite that, there are still numerous studies on the improvement of this drug delivery system aiming at enhancing drug loading into cells by using specific interactions

• . Moreover, it was shown that the surface concentration of the drug on the electrode surface is similar for both the drug in a free form and the drug–nanocarrier adduct. This observation proves that application of single-walled carbon nanotubes as drug delivery system allows for the transport of the

pH-Triggered release from surface-modified poly(lactic-co-glycolic acid) nanoparticles

• Manuel Häuser,
• Klaus Langer and
• Monika Schönhoff

Beilstein J. Nanotechnol. 2015, 6, 2504–2512, doi:10.3762/bjnano.6.260

• Nanoparticles (NP) of poly(lactic-co-glycolic acid) (PLGA) represent a promising biodegradable drug delivery system. We suggest here a two-step release system of PLGA nanoparticles with a pH-tunable polymeric shell, providing an initial pH-triggered step, releasing a membrane-toxic cationic compound. PLGA

Nanofibers for drug delivery – incorporation and release of model molecules, influence of molecular weight and polymer structure

• Jakub Hrib,
• Jakub Sirc,
• Radka Hobzova,
• Zuzana Hampejsova,
• Zuzana Bosakova,
• Marcela Munzarova and
• Jiri Michalek

Beilstein J. Nanotechnol. 2015, 6, 1939–1945, doi:10.3762/bjnano.6.198

• delivery system with the diffusion rate of the therapeutic agent stable throughout the life. The structure of the nanofibrous drug delivery system plays a key role in the drug release process. The fiber diameter, specific surface area, size and total volume of pores significantly influence the convection

Filling of carbon nanotubes and nanofibres

• Reece D. Gately and
• Marc in het Panhuis

Beilstein J. Nanotechnol. 2015, 6, 508–516, doi:10.3762/bjnano.6.53

• delivery and medical imaging applications of SWCNT and MWCNTs have been identified, this line of research has only very recently emerged [117][118][119]. Further investigations into the selective binding of functional groups and various viruses or tumours could provide for an effective drug delivery system